FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer

A controlled and prospective study

Jee In Kang, Hyuncheol Chung, Hei Cheul Jeung, Se Joo Kim, Suk Kyoon An, Kee Namkoong

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

Cancer patients, who have to adapt to a long treatment process with multiple stressful events, show various stress responses. Genetic components may contribute to individual differences in stress response and risk for development of stress-related psychiatric problems. The present study aimed to investigate the influence of FK506 binding protein 5 (FKBP5) gene polymorphisms regulating the hypothalamic-pituitary-adrenal (HPA) axis on individual distress levels in cancer patients faced with similar stressful situation. The present study used a prospective design to elucidate predictors of distress. A total of 130 patients (90 males, 40 females) who were newly diagnosed with advanced gastric cancer and supposed to receive first-line chemotherapy were initially assessed, and a six-week follow-up assessment occurred for 93 patients (63 males, 30 females) after two cycles of chemotherapy. Distress levels and coping patterns were measured by the Hospital Anxiety and Depression Scale (HADS) and Mini-Mental Adjustment to Cancer (Mini-MAC) scale. For genetic factors, three single nucleotide polymorphisms of FKBP5 rs1360780, rs9296158 and rs9470080 were genotyped. For HADS-anxiety, FKBP5 rs9296158 had a significant group-by-time interaction (p= 0.015), and rs9470080 and rs1360780 had a marginally significant interaction (p= 0.023, p= 0.038, respectively). For HADS-depression, rs9470080 and rs9296158 had a marginally significant group-by-time interaction (p= 0.026, p= 0.032, respectively). In addition, a step-wise linear regression analysis showed that FKBP5 rs9470080 and rs9296158 were significant predictors of anxiety and depression after prolonged stress exposure in cancer patients. Our findings indicate that the genetic factors regulating the HPA axis such as FKBP5 gene polymorphisms may play a crucial role in anxiety and depression following prolonged stress exposure.

Original languageEnglish
Pages (from-to)1569-1576
Number of pages8
JournalPsychoneuroendocrinology
Volume37
Issue number9
DOIs
Publication statusPublished - 2012 Sep 1

Fingerprint

Stomach Neoplasms
Anxiety
Prospective Studies
Depression
Neoplasms
Social Adjustment
Drug Therapy
Individuality
Genes
Single Nucleotide Polymorphism
Psychiatry
tacrolimus binding protein 5
Linear Models
Regression Analysis

All Science Journal Classification (ASJC) codes

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology
  • Endocrine and Autonomic Systems
  • Psychiatry and Mental health
  • Biological Psychiatry

Cite this

Kang, Jee In ; Chung, Hyuncheol ; Jeung, Hei Cheul ; Kim, Se Joo ; An, Suk Kyoon ; Namkoong, Kee. / FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer : A controlled and prospective study. In: Psychoneuroendocrinology. 2012 ; Vol. 37, No. 9. pp. 1569-1576.
@article{fb1aff6262e84fba8167b779822b648b,
title = "FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer: A controlled and prospective study",
abstract = "Cancer patients, who have to adapt to a long treatment process with multiple stressful events, show various stress responses. Genetic components may contribute to individual differences in stress response and risk for development of stress-related psychiatric problems. The present study aimed to investigate the influence of FK506 binding protein 5 (FKBP5) gene polymorphisms regulating the hypothalamic-pituitary-adrenal (HPA) axis on individual distress levels in cancer patients faced with similar stressful situation. The present study used a prospective design to elucidate predictors of distress. A total of 130 patients (90 males, 40 females) who were newly diagnosed with advanced gastric cancer and supposed to receive first-line chemotherapy were initially assessed, and a six-week follow-up assessment occurred for 93 patients (63 males, 30 females) after two cycles of chemotherapy. Distress levels and coping patterns were measured by the Hospital Anxiety and Depression Scale (HADS) and Mini-Mental Adjustment to Cancer (Mini-MAC) scale. For genetic factors, three single nucleotide polymorphisms of FKBP5 rs1360780, rs9296158 and rs9470080 were genotyped. For HADS-anxiety, FKBP5 rs9296158 had a significant group-by-time interaction (p= 0.015), and rs9470080 and rs1360780 had a marginally significant interaction (p= 0.023, p= 0.038, respectively). For HADS-depression, rs9470080 and rs9296158 had a marginally significant group-by-time interaction (p= 0.026, p= 0.032, respectively). In addition, a step-wise linear regression analysis showed that FKBP5 rs9470080 and rs9296158 were significant predictors of anxiety and depression after prolonged stress exposure in cancer patients. Our findings indicate that the genetic factors regulating the HPA axis such as FKBP5 gene polymorphisms may play a crucial role in anxiety and depression following prolonged stress exposure.",
author = "Kang, {Jee In} and Hyuncheol Chung and Jeung, {Hei Cheul} and Kim, {Se Joo} and An, {Suk Kyoon} and Kee Namkoong",
year = "2012",
month = "9",
day = "1",
doi = "10.1016/j.psyneuen.2012.02.017",
language = "English",
volume = "37",
pages = "1569--1576",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "9",

}

FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer : A controlled and prospective study. / Kang, Jee In; Chung, Hyuncheol; Jeung, Hei Cheul; Kim, Se Joo; An, Suk Kyoon; Namkoong, Kee.

In: Psychoneuroendocrinology, Vol. 37, No. 9, 01.09.2012, p. 1569-1576.

Research output: Contribution to journalArticle

TY - JOUR

T1 - FKBP5 polymorphisms as vulnerability to anxiety and depression in patients with advanced gastric cancer

T2 - A controlled and prospective study

AU - Kang, Jee In

AU - Chung, Hyuncheol

AU - Jeung, Hei Cheul

AU - Kim, Se Joo

AU - An, Suk Kyoon

AU - Namkoong, Kee

PY - 2012/9/1

Y1 - 2012/9/1

N2 - Cancer patients, who have to adapt to a long treatment process with multiple stressful events, show various stress responses. Genetic components may contribute to individual differences in stress response and risk for development of stress-related psychiatric problems. The present study aimed to investigate the influence of FK506 binding protein 5 (FKBP5) gene polymorphisms regulating the hypothalamic-pituitary-adrenal (HPA) axis on individual distress levels in cancer patients faced with similar stressful situation. The present study used a prospective design to elucidate predictors of distress. A total of 130 patients (90 males, 40 females) who were newly diagnosed with advanced gastric cancer and supposed to receive first-line chemotherapy were initially assessed, and a six-week follow-up assessment occurred for 93 patients (63 males, 30 females) after two cycles of chemotherapy. Distress levels and coping patterns were measured by the Hospital Anxiety and Depression Scale (HADS) and Mini-Mental Adjustment to Cancer (Mini-MAC) scale. For genetic factors, three single nucleotide polymorphisms of FKBP5 rs1360780, rs9296158 and rs9470080 were genotyped. For HADS-anxiety, FKBP5 rs9296158 had a significant group-by-time interaction (p= 0.015), and rs9470080 and rs1360780 had a marginally significant interaction (p= 0.023, p= 0.038, respectively). For HADS-depression, rs9470080 and rs9296158 had a marginally significant group-by-time interaction (p= 0.026, p= 0.032, respectively). In addition, a step-wise linear regression analysis showed that FKBP5 rs9470080 and rs9296158 were significant predictors of anxiety and depression after prolonged stress exposure in cancer patients. Our findings indicate that the genetic factors regulating the HPA axis such as FKBP5 gene polymorphisms may play a crucial role in anxiety and depression following prolonged stress exposure.

AB - Cancer patients, who have to adapt to a long treatment process with multiple stressful events, show various stress responses. Genetic components may contribute to individual differences in stress response and risk for development of stress-related psychiatric problems. The present study aimed to investigate the influence of FK506 binding protein 5 (FKBP5) gene polymorphisms regulating the hypothalamic-pituitary-adrenal (HPA) axis on individual distress levels in cancer patients faced with similar stressful situation. The present study used a prospective design to elucidate predictors of distress. A total of 130 patients (90 males, 40 females) who were newly diagnosed with advanced gastric cancer and supposed to receive first-line chemotherapy were initially assessed, and a six-week follow-up assessment occurred for 93 patients (63 males, 30 females) after two cycles of chemotherapy. Distress levels and coping patterns were measured by the Hospital Anxiety and Depression Scale (HADS) and Mini-Mental Adjustment to Cancer (Mini-MAC) scale. For genetic factors, three single nucleotide polymorphisms of FKBP5 rs1360780, rs9296158 and rs9470080 were genotyped. For HADS-anxiety, FKBP5 rs9296158 had a significant group-by-time interaction (p= 0.015), and rs9470080 and rs1360780 had a marginally significant interaction (p= 0.023, p= 0.038, respectively). For HADS-depression, rs9470080 and rs9296158 had a marginally significant group-by-time interaction (p= 0.026, p= 0.032, respectively). In addition, a step-wise linear regression analysis showed that FKBP5 rs9470080 and rs9296158 were significant predictors of anxiety and depression after prolonged stress exposure in cancer patients. Our findings indicate that the genetic factors regulating the HPA axis such as FKBP5 gene polymorphisms may play a crucial role in anxiety and depression following prolonged stress exposure.

UR - http://www.scopus.com/inward/record.url?scp=84864772058&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864772058&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2012.02.017

DO - 10.1016/j.psyneuen.2012.02.017

M3 - Article

VL - 37

SP - 1569

EP - 1576

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 9

ER -